Up-and-coming markers: Myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application?

Congestive Heart Failure

Volumn 14, Issue 4, 2008, Pages 46-48

  Sinning, Christoph ^a   Schnabel, Renate ^a   Peacock, W Frank ^b   Blankenberg, Stefan ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEROXIDASE;

ACUTE CORONARY SYNDROME; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; HEART FAILURE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HEART FAILURE; HUMANS; PEROXIDASE;

EID: 55249101700     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2008.08334.x     Document Type: Review

References (19)

1. Apple FS, Wu AH, Mair J, et al. Future bio-markers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005;51(5):810-824.
2. Eiserich JP, Baldus S, Brennan ML, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science. 2002;296(5577):2391-2394.
3. Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med. 2000;28(12):1717-1725.
4. Mocatta TJ, Pilbrow AP, Cameron VA, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol. 2007;49(20):1993-2000.
5. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108(12):1440-1445.
6. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349(17):1595-1604.
7. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;25(6):1102-1111.
8. Baldus S, Heitzer T, Eiserich JP, et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med. 2004;37(6):902-911.
9. Rudolph V, Rudolph TK, Hennings JC, et al. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic Biol Med. 2007;43(8):1189-1196.
10. Tang WH, Brennan ML, Philip K, et al. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol. 2006;98(6):796-799.
11. Cameron VA, Mocatta TJ, Pilbrow AP, et al. Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension. 2006;47(6):1155-1161.
12. Askari AT, Brennan ML, Zhou X, et al. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med. 2003;197(5):615-624.
13. Baldus S, Rudolph V, Roiss M, et al. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation. 2006;113(15):1871-1878.
14. Tang WH, Tong W, Troughton RW, et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol. 2007;49(24):2364-2370.
15. Ng LL, Pathik B, Loke I W, et al. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am Heart J. 2006;152(1):94-101.
16. Biasucci LM, D'Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 1996;27(3):611-616.
17. Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286(17):2136-2142.
18. Meuwese MC, Stroes ES, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007;50(2):159-165.
19. Vita JA, Brennan ML, Gokce N, et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110(9):1134-1139.